Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 15, 2011

Premium

NanoString Technologies this week made two appointments to its commercial management team. Chris Grimley has been named vice president of marketing and Katherine Webster has been named vice president of worldwide sales.

Grimley joins NanoString from Agilent Technologies, where he was senior director of genomics marketing. Before that, he spent 14 years in various product management positions at Applied Biosystems, now Life Technologies. Grimley previously was a research associate at Genentech. He holds a BSc in biochemistry from San Francisco State University.

Webster joins NanoString from Qiagen where she was senior sales director for the company's Life Science business. She previously held management positions at 454 Life Sciences, now a Roche company; Biotage; Celera Genomics; and Applied Biosystems. Webster holds a BSc in chemistry from the State University of New York at Syracuse.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.